o Outpatient Treatment The development of this program is in response to the continued prevalence of opioid addiction in New Jersey and across the country. In the first half of 2020, New Jersey had a 13% increase in drug overdose deaths compared to 2019, as tallied by NJCARES. "This is an area where we see an unmet need in the communities we treat," says Arel Meister-Aldama, CEO Sprout Health Group. "It is our mission at Sprout to provide quality treatment programs that recognize each client's unique struggles and provide services that can improve their odds for achieving long-term recovery for behavioral health challenges. Medication Assisted Treatment needs to be an option for those struggling with addiction."